Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
about
Meta-analysis of proportion estimates of Extended-Spectrum-Beta-Lactamase-producing Enterobacteriaceae in East Africa hospitalsBacterial Infections in Hematopoietic Stem Cell Transplant RecipientsCarbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysisThere should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacyAntibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies.European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in LeukemiaRecent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance.Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneityIncrease in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes.Ten-year surveillance of nosocomial bloodstream infections: trends of aetiology and antimicrobial resistance in a comprehensive cancer centreIn vitro activities of 21 antimicrobial agents alone and in combination with aminoglycosides or fluoroquinolones against extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremiaBloodstream infections in neutropenic cancer patients: A practical update.Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrosCharacterization of integrons among Escherichia coli in a region at high incidence of ESBL-EC.Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis.The prevention and management of infections due to multidrug resistant organisms in haematology patientsColonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - Review of the literature from a clinical perspective.Antibiotic resistance in cancer patients.Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia.Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: Three major threats to hematopoietic stem cell transplant recipients.Colonization and infection with extended-spectrum beta-lactamase producing Enterobacteriaceae in patients with malignancy.Comparison Between Carbapenems and β-Lactam/β-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis.Bloodstream infections in patients with solid tumors.The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies.Managing the oncologic patient with suspected pneumonia in the intensive care unit.Prevalence and risk factors of Gram-negative bacilli causing blood stream infection in patients with malignancyEfficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.P. aeruginosa bloodstream infections among hematological patients: an old or new question?Mortality in Patients With Septic Shock by Multidrug Resistant Bacteria.Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013.Risk factors and scoring system for predicting bacterial resistance to cefepime as used empirically in haematology wards.Improving the outcome of bloodstream infection in patients with hematological malignancies: looking beyond antibiotics.Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia.Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia.
P2860
Q26749161-7F6492AC-8668-447A-8FC2-FDD2BBF8D4E2Q26799576-C30B9403-4F76-476F-A1BF-BBC2437245A6Q27002495-303A57DB-FAEA-43E8-8783-CDB872A13397Q27005826-59722399-190F-47A4-96B6-A357EFB621E8Q30238945-3D8A90B5-E6E9-4DC0-8A43-1556E039AFD3Q33760545-D789B25A-38F0-4245-B50A-FE7DF8BACB4CQ34249389-7D10FC4E-4078-49E5-A6B3-B6DA89B4E93DQ34390823-B6AAEEDA-5231-403F-AEDD-5D4E1222CDEAQ34564797-56FF4419-8981-4CCF-AFDF-D74228558701Q34571008-14E0722D-26A5-4A67-BCA5-86F695546F4CQ34999291-AD0583A5-8685-4FE1-A7D6-FF2F0B3E4D7BQ35572742-25860106-6EF6-40EA-AF70-C15A1E59E9B2Q35961012-82478846-E9FA-4333-9C15-897B01FD1C7BQ36913345-1F6832FA-62EC-42B7-AD77-392A92411BD6Q37023242-15DC4FAD-0494-49B8-AF2F-05027D5E6C0DQ37612207-C929C920-C544-4053-81E9-8041878542E4Q37639669-761FB586-CBDD-4BA7-B559-1122696D72ABQ37991287-E043F5E5-F3D3-4A71-B763-A83DF0527239Q38171538-EEB9E645-BA7C-4831-9DBD-C1BD0260FD02Q38185120-287A8B60-FD0C-47ED-B1FE-4D6B6747BC92Q38212258-B90C8B7A-E1D5-4265-B9E2-7A7A09CBF916Q38467189-7319AA42-A1DF-49C9-9DCE-5E1837169336Q38474339-D77ACDBA-4ECD-4C31-BC2E-4216642FACCFQ38620812-D04A10DB-0476-404C-8E37-217C55DF3A4DQ38665505-7413DF50-F73F-4CA1-B93C-DE70489454CAQ38681779-4D6D4C64-E161-432B-8550-654005C7ADA6Q38703440-794A6DBD-63C4-4338-91A4-91D62005F871Q38875315-C1D02A3C-9937-4CF3-9261-95D93A5F398DQ38940456-D629401A-BB78-4214-B5DD-713181530006Q39444336-F60CEF15-9EA4-447E-B1C6-694FD937626DQ40184233-7AF965D2-F123-4F87-8649-A4839AEE5200Q40267702-4608BCF6-DDA6-4038-BE0A-BA4F16018336Q40295711-F4AF3949-F5B7-44B8-9CA2-6D1116F64011Q40366928-247F219A-403A-4274-B473-8628836CF550Q40593048-B32DB32A-731C-4400-828B-EDA031CE60F4Q40706134-6929D616-094A-4C7F-93B9-475491B5E701Q40812219-7C31F639-D04A-4F22-821B-3A3AC1AAD2FFQ41151969-51F0D47B-81FD-4E21-B1B3-75D051A5BD31Q41552096-29F3A24B-FB8A-4CB7-B95B-2F27554D3AF7Q41948199-4208B2AC-7214-463F-94A7-F81347A51B1D
P2860
Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Bacteraemia due to extended-sp ...... ular epidemiology and outcome.
@en
Bacteraemia due to extended-sp ...... ular epidemiology and outcome.
@nl
type
label
Bacteraemia due to extended-sp ...... ular epidemiology and outcome.
@en
Bacteraemia due to extended-sp ...... ular epidemiology and outcome.
@nl
prefLabel
Bacteraemia due to extended-sp ...... ular epidemiology and outcome.
@en
Bacteraemia due to extended-sp ...... ular epidemiology and outcome.
@nl
P2093
P356
P1476
Bacteraemia due to extended-sp ...... cular epidemiology and outcome
@en
P2093
Carlota Gudiol
Francesc Gudiol
Jaime Lora-Tamayo
Laura Calatayud
María Cisnal
Montserrat Arnan
Rafael Duarte
P304
P356
10.1093/JAC/DKP411
P407
P577
2009-12-03T00:00:00Z